Review



lung alveolar basal epithelial cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC lung alveolar basal epithelial cells
    Lung Alveolar Basal Epithelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 35523 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lung alveolar basal epithelial cells/product/ATCC
    Average 99 stars, based on 35523 article reviews
    lung alveolar basal epithelial cells - by Bioz Stars, 2026-02
    99/100 stars

    Images



    Similar Products

    99
    ATCC lung alveolar basal epithelial cells
    Lung Alveolar Basal Epithelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lung alveolar basal epithelial cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    lung alveolar basal epithelial cells - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    ATCC small cell lung cancer derived hypotriploid alveolar basal epithelial cells a549
    Characterisation and function analysis of 1,4‐D‐induced EVs in WT and Nrf2 KO cells. (A) Immunoblots showing the expression of PDCD6IP, CD82, CD9, CANX and ACTB in cell lysates and EV samples derived from WT, 1,4‐D‐transformed WT, Nrf2 KO and 1,4‐D‐transformed Nrf2 KO cells. (B) Representative TEM photographs of EVs from the indicated groups. (C and D) EV concentrations across the groups, with 1,4‐D‐induced changes in EV production in WT and Nrf2 KO cells shown as fold changes. Data are presented as mean ± SD, n = 3, * p < 0.05 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (E and F) Size distribution of EVs in each group, determined and quantified using NTA. Data are presented as mean ± SD, n = 3, * p < 0.05 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (G) Effects of EVs from 1,4‐D‐transformed WT (T‐WT) and 1,4‐D‐transformed Nrf2 KO (T‐Nrf2 KO) cells on <t>A549</t> cell proliferation. Data are presented as mean ± SD, n = 6, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (H–J) Representative images illustrating changes in migration and invasion capabilities of A549 cells treated with EVs from the indicated groups, with quantification of migrated or invasive cells. Data are presented as mean ± SD, n = 10, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test).
    Small Cell Lung Cancer Derived Hypotriploid Alveolar Basal Epithelial Cells A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/small cell lung cancer derived hypotriploid alveolar basal epithelial cells a549/product/ATCC
    Average 99 stars, based on 1 article reviews
    small cell lung cancer derived hypotriploid alveolar basal epithelial cells a549 - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    ATCC non small cell lung cancer derived hypotriploid alveolar basal epithelial cells a549
    Characterisation and function analysis of 1,4‐D‐induced EVs in WT and Nrf2 KO cells. (A) Immunoblots showing the expression of PDCD6IP, CD82, CD9, CANX and ACTB in cell lysates and EV samples derived from WT, 1,4‐D‐transformed WT, Nrf2 KO and 1,4‐D‐transformed Nrf2 KO cells. (B) Representative TEM photographs of EVs from the indicated groups. (C and D) EV concentrations across the groups, with 1,4‐D‐induced changes in EV production in WT and Nrf2 KO cells shown as fold changes. Data are presented as mean ± SD, n = 3, * p < 0.05 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (E and F) Size distribution of EVs in each group, determined and quantified using NTA. Data are presented as mean ± SD, n = 3, * p < 0.05 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (G) Effects of EVs from 1,4‐D‐transformed WT (T‐WT) and 1,4‐D‐transformed Nrf2 KO (T‐Nrf2 KO) cells on <t>A549</t> cell proliferation. Data are presented as mean ± SD, n = 6, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (H–J) Representative images illustrating changes in migration and invasion capabilities of A549 cells treated with EVs from the indicated groups, with quantification of migrated or invasive cells. Data are presented as mean ± SD, n = 10, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test).
    Non Small Cell Lung Cancer Derived Hypotriploid Alveolar Basal Epithelial Cells A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/non small cell lung cancer derived hypotriploid alveolar basal epithelial cells a549/product/ATCC
    Average 99 stars, based on 1 article reviews
    non small cell lung cancer derived hypotriploid alveolar basal epithelial cells a549 - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    ATCC a549 adenocarcinoma human alveolar basal epithelial lung carcinoma cells
    Characterisation and function analysis of 1,4‐D‐induced EVs in WT and Nrf2 KO cells. (A) Immunoblots showing the expression of PDCD6IP, CD82, CD9, CANX and ACTB in cell lysates and EV samples derived from WT, 1,4‐D‐transformed WT, Nrf2 KO and 1,4‐D‐transformed Nrf2 KO cells. (B) Representative TEM photographs of EVs from the indicated groups. (C and D) EV concentrations across the groups, with 1,4‐D‐induced changes in EV production in WT and Nrf2 KO cells shown as fold changes. Data are presented as mean ± SD, n = 3, * p < 0.05 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (E and F) Size distribution of EVs in each group, determined and quantified using NTA. Data are presented as mean ± SD, n = 3, * p < 0.05 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (G) Effects of EVs from 1,4‐D‐transformed WT (T‐WT) and 1,4‐D‐transformed Nrf2 KO (T‐Nrf2 KO) cells on <t>A549</t> cell proliferation. Data are presented as mean ± SD, n = 6, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (H–J) Representative images illustrating changes in migration and invasion capabilities of A549 cells treated with EVs from the indicated groups, with quantification of migrated or invasive cells. Data are presented as mean ± SD, n = 10, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test).
    A549 Adenocarcinoma Human Alveolar Basal Epithelial Lung Carcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a549 adenocarcinoma human alveolar basal epithelial lung carcinoma cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    a549 adenocarcinoma human alveolar basal epithelial lung carcinoma cells - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    ATCC human lung alveolar basal epithelial cells for adenocarcinoma
    Characterisation and function analysis of 1,4‐D‐induced EVs in WT and Nrf2 KO cells. (A) Immunoblots showing the expression of PDCD6IP, CD82, CD9, CANX and ACTB in cell lysates and EV samples derived from WT, 1,4‐D‐transformed WT, Nrf2 KO and 1,4‐D‐transformed Nrf2 KO cells. (B) Representative TEM photographs of EVs from the indicated groups. (C and D) EV concentrations across the groups, with 1,4‐D‐induced changes in EV production in WT and Nrf2 KO cells shown as fold changes. Data are presented as mean ± SD, n = 3, * p < 0.05 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (E and F) Size distribution of EVs in each group, determined and quantified using NTA. Data are presented as mean ± SD, n = 3, * p < 0.05 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (G) Effects of EVs from 1,4‐D‐transformed WT (T‐WT) and 1,4‐D‐transformed Nrf2 KO (T‐Nrf2 KO) cells on <t>A549</t> cell proliferation. Data are presented as mean ± SD, n = 6, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (H–J) Representative images illustrating changes in migration and invasion capabilities of A549 cells treated with EVs from the indicated groups, with quantification of migrated or invasive cells. Data are presented as mean ± SD, n = 10, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test).
    Human Lung Alveolar Basal Epithelial Cells For Adenocarcinoma, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human lung alveolar basal epithelial cells for adenocarcinoma/product/ATCC
    Average 99 stars, based on 1 article reviews
    human lung alveolar basal epithelial cells for adenocarcinoma - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    90
    National Centre for Cell Science adherent adenocarcinoma human alveolar basal epithelial a459 lung cancer cell line
    Characterisation and function analysis of 1,4‐D‐induced EVs in WT and Nrf2 KO cells. (A) Immunoblots showing the expression of PDCD6IP, CD82, CD9, CANX and ACTB in cell lysates and EV samples derived from WT, 1,4‐D‐transformed WT, Nrf2 KO and 1,4‐D‐transformed Nrf2 KO cells. (B) Representative TEM photographs of EVs from the indicated groups. (C and D) EV concentrations across the groups, with 1,4‐D‐induced changes in EV production in WT and Nrf2 KO cells shown as fold changes. Data are presented as mean ± SD, n = 3, * p < 0.05 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (E and F) Size distribution of EVs in each group, determined and quantified using NTA. Data are presented as mean ± SD, n = 3, * p < 0.05 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (G) Effects of EVs from 1,4‐D‐transformed WT (T‐WT) and 1,4‐D‐transformed Nrf2 KO (T‐Nrf2 KO) cells on <t>A549</t> cell proliferation. Data are presented as mean ± SD, n = 6, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (H–J) Representative images illustrating changes in migration and invasion capabilities of A549 cells treated with EVs from the indicated groups, with quantification of migrated or invasive cells. Data are presented as mean ± SD, n = 10, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test).
    Adherent Adenocarcinoma Human Alveolar Basal Epithelial A459 Lung Cancer Cell Line, supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/adherent adenocarcinoma human alveolar basal epithelial a459 lung cancer cell line/product/National Centre for Cell Science
    Average 90 stars, based on 1 article reviews
    adherent adenocarcinoma human alveolar basal epithelial a459 lung cancer cell line - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    99
    ATCC a549 human lung adenocarcinomic alveolar basal epithelial cell lines
    Characterisation and function analysis of 1,4‐D‐induced EVs in WT and Nrf2 KO cells. (A) Immunoblots showing the expression of PDCD6IP, CD82, CD9, CANX and ACTB in cell lysates and EV samples derived from WT, 1,4‐D‐transformed WT, Nrf2 KO and 1,4‐D‐transformed Nrf2 KO cells. (B) Representative TEM photographs of EVs from the indicated groups. (C and D) EV concentrations across the groups, with 1,4‐D‐induced changes in EV production in WT and Nrf2 KO cells shown as fold changes. Data are presented as mean ± SD, n = 3, * p < 0.05 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (E and F) Size distribution of EVs in each group, determined and quantified using NTA. Data are presented as mean ± SD, n = 3, * p < 0.05 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (G) Effects of EVs from 1,4‐D‐transformed WT (T‐WT) and 1,4‐D‐transformed Nrf2 KO (T‐Nrf2 KO) cells on <t>A549</t> cell proliferation. Data are presented as mean ± SD, n = 6, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (H–J) Representative images illustrating changes in migration and invasion capabilities of A549 cells treated with EVs from the indicated groups, with quantification of migrated or invasive cells. Data are presented as mean ± SD, n = 10, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test).
    A549 Human Lung Adenocarcinomic Alveolar Basal Epithelial Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a549 human lung adenocarcinomic alveolar basal epithelial cell lines/product/ATCC
    Average 99 stars, based on 1 article reviews
    a549 human lung adenocarcinomic alveolar basal epithelial cell lines - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    Image Search Results


    Characterisation and function analysis of 1,4‐D‐induced EVs in WT and Nrf2 KO cells. (A) Immunoblots showing the expression of PDCD6IP, CD82, CD9, CANX and ACTB in cell lysates and EV samples derived from WT, 1,4‐D‐transformed WT, Nrf2 KO and 1,4‐D‐transformed Nrf2 KO cells. (B) Representative TEM photographs of EVs from the indicated groups. (C and D) EV concentrations across the groups, with 1,4‐D‐induced changes in EV production in WT and Nrf2 KO cells shown as fold changes. Data are presented as mean ± SD, n = 3, * p < 0.05 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (E and F) Size distribution of EVs in each group, determined and quantified using NTA. Data are presented as mean ± SD, n = 3, * p < 0.05 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (G) Effects of EVs from 1,4‐D‐transformed WT (T‐WT) and 1,4‐D‐transformed Nrf2 KO (T‐Nrf2 KO) cells on A549 cell proliferation. Data are presented as mean ± SD, n = 6, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (H–J) Representative images illustrating changes in migration and invasion capabilities of A549 cells treated with EVs from the indicated groups, with quantification of migrated or invasive cells. Data are presented as mean ± SD, n = 10, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test).

    Journal: Journal of Extracellular Vesicles

    Article Title: 1,4‐Dioxane Induces Epithelial‐Mesenchymal Transition and Carcinogenesis in an Nrf2‐Dependent Manner

    doi: 10.1002/jev2.70072

    Figure Lengend Snippet: Characterisation and function analysis of 1,4‐D‐induced EVs in WT and Nrf2 KO cells. (A) Immunoblots showing the expression of PDCD6IP, CD82, CD9, CANX and ACTB in cell lysates and EV samples derived from WT, 1,4‐D‐transformed WT, Nrf2 KO and 1,4‐D‐transformed Nrf2 KO cells. (B) Representative TEM photographs of EVs from the indicated groups. (C and D) EV concentrations across the groups, with 1,4‐D‐induced changes in EV production in WT and Nrf2 KO cells shown as fold changes. Data are presented as mean ± SD, n = 3, * p < 0.05 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (E and F) Size distribution of EVs in each group, determined and quantified using NTA. Data are presented as mean ± SD, n = 3, * p < 0.05 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (G) Effects of EVs from 1,4‐D‐transformed WT (T‐WT) and 1,4‐D‐transformed Nrf2 KO (T‐Nrf2 KO) cells on A549 cell proliferation. Data are presented as mean ± SD, n = 6, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (H–J) Representative images illustrating changes in migration and invasion capabilities of A549 cells treated with EVs from the indicated groups, with quantification of migrated or invasive cells. Data are presented as mean ± SD, n = 10, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test).

    Article Snippet: The human bronchial epithelial cell line BEAS‐2B and the human non‐small cell lung cancer derived hypotriploid alveolar basal epithelial cells A549, purchased from the American Type Culture Collection (ATCC, Manassas, VA), were maintained in complete medium at 37°C under 5% CO 2 .

    Techniques: Western Blot, Expressing, Derivative Assay, Transformation Assay, Control, Migration

    Nrf2 activation induced by 1,4‐D promotes EMT protein loading in EVs. (A) Venn diagram illustrating 359 1,4‐D‐induced, Nrf2‐dependent proteins identified in cell lysate proteomics, significantly enriched in ROS and fatty acid metabolism pathways. (B) Venny diagram illustrating 173 1,4‐D‐induced, Nrf2‐dependent proteins identified in EV proteomics, significantly enriched in the MYC and EMT pathways. (C) Overlapping proteins between the EV and cell proteomes are significantly enriched in ROS, mTORC1 signalling and glycolysis pathways. A heatmap illustrates the abundance of overlapped 1,4‐D‐induced, Nrf2‐dependent proteins in EVs and cell lysates, which are also associated with EMT. Protein abundances are shown as log2 fold changes. (D) Pathway enrichment analysis (Hallmark collection) reveals significant enrichment of the EMT pathway among genes overlapping between the EV proteome and cell transcriptome. (E) Heatmap displaying the protein abundance and gene expression of SFRP1, MMP14, BMP1, SDC4, ITGB3, COL12A1, COL5A2, ITGAV, PVR and FERMT2 in EV samples and cells. These proteins are expressed in a 1,4‐D‐induced, Nrf2‐dependent manner and are significantly enriched in the EMT pathway. Data are shown as log2 fold changes. (F) Representative immunoblots showing the abundance of SDC4, COL12A1, CAPG, NNMT, MMP14, SLUG, NANOG, VIM, TWIST1 and ACTB in A549 recipient cells following 24‐h EV treatment.

    Journal: Journal of Extracellular Vesicles

    Article Title: 1,4‐Dioxane Induces Epithelial‐Mesenchymal Transition and Carcinogenesis in an Nrf2‐Dependent Manner

    doi: 10.1002/jev2.70072

    Figure Lengend Snippet: Nrf2 activation induced by 1,4‐D promotes EMT protein loading in EVs. (A) Venn diagram illustrating 359 1,4‐D‐induced, Nrf2‐dependent proteins identified in cell lysate proteomics, significantly enriched in ROS and fatty acid metabolism pathways. (B) Venny diagram illustrating 173 1,4‐D‐induced, Nrf2‐dependent proteins identified in EV proteomics, significantly enriched in the MYC and EMT pathways. (C) Overlapping proteins between the EV and cell proteomes are significantly enriched in ROS, mTORC1 signalling and glycolysis pathways. A heatmap illustrates the abundance of overlapped 1,4‐D‐induced, Nrf2‐dependent proteins in EVs and cell lysates, which are also associated with EMT. Protein abundances are shown as log2 fold changes. (D) Pathway enrichment analysis (Hallmark collection) reveals significant enrichment of the EMT pathway among genes overlapping between the EV proteome and cell transcriptome. (E) Heatmap displaying the protein abundance and gene expression of SFRP1, MMP14, BMP1, SDC4, ITGB3, COL12A1, COL5A2, ITGAV, PVR and FERMT2 in EV samples and cells. These proteins are expressed in a 1,4‐D‐induced, Nrf2‐dependent manner and are significantly enriched in the EMT pathway. Data are shown as log2 fold changes. (F) Representative immunoblots showing the abundance of SDC4, COL12A1, CAPG, NNMT, MMP14, SLUG, NANOG, VIM, TWIST1 and ACTB in A549 recipient cells following 24‐h EV treatment.

    Article Snippet: The human bronchial epithelial cell line BEAS‐2B and the human non‐small cell lung cancer derived hypotriploid alveolar basal epithelial cells A549, purchased from the American Type Culture Collection (ATCC, Manassas, VA), were maintained in complete medium at 37°C under 5% CO 2 .

    Techniques: Activation Assay, Quantitative Proteomics, Gene Expression, Western Blot

    1,4‐D‐induced, SDC4‐enriched EVs are significantly internalised by recipient cells. (A) Effects of Nrf2 knockout on the expression of key EV biomarkers based on EV proteomics. Data are shown as log2 fold changes. (B) Representative immunoblots showing the abundance of SDC4 in EVs derived from the indicated groups. (C) Representative immunoblots showing SDC4 abundance in WT cells transformed by 1,4‐D at concentrations ranging from 1.25 to 20 ppm. (D) Representative immunoblots displaying SDC4 expression in EVs derived from WT and Nrf2 KO cells transformed by 1,4‐D at concentrations ranging from 1.25 to 20 ppm. (E) Representative SDC4 staining of A549 cells after 24‐h treatment with PKH67‐labelled EVs derived from WT, 1,4‐D‐transformed WT, Nrf2 KO and 1,4‐D‐transformed Nrf2 KO cell groups. (F) Quantification results of PKH67 and SDC4 intensities, along with Pearson's correlation and Mander's overlap, are shown for the co‐localisation between PKH67‐labelled EVs and SDC4. Data are presented as mean ± SD, n = 10, * p < 0.05, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test).

    Journal: Journal of Extracellular Vesicles

    Article Title: 1,4‐Dioxane Induces Epithelial‐Mesenchymal Transition and Carcinogenesis in an Nrf2‐Dependent Manner

    doi: 10.1002/jev2.70072

    Figure Lengend Snippet: 1,4‐D‐induced, SDC4‐enriched EVs are significantly internalised by recipient cells. (A) Effects of Nrf2 knockout on the expression of key EV biomarkers based on EV proteomics. Data are shown as log2 fold changes. (B) Representative immunoblots showing the abundance of SDC4 in EVs derived from the indicated groups. (C) Representative immunoblots showing SDC4 abundance in WT cells transformed by 1,4‐D at concentrations ranging from 1.25 to 20 ppm. (D) Representative immunoblots displaying SDC4 expression in EVs derived from WT and Nrf2 KO cells transformed by 1,4‐D at concentrations ranging from 1.25 to 20 ppm. (E) Representative SDC4 staining of A549 cells after 24‐h treatment with PKH67‐labelled EVs derived from WT, 1,4‐D‐transformed WT, Nrf2 KO and 1,4‐D‐transformed Nrf2 KO cell groups. (F) Quantification results of PKH67 and SDC4 intensities, along with Pearson's correlation and Mander's overlap, are shown for the co‐localisation between PKH67‐labelled EVs and SDC4. Data are presented as mean ± SD, n = 10, * p < 0.05, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test).

    Article Snippet: The human bronchial epithelial cell line BEAS‐2B and the human non‐small cell lung cancer derived hypotriploid alveolar basal epithelial cells A549, purchased from the American Type Culture Collection (ATCC, Manassas, VA), were maintained in complete medium at 37°C under 5% CO 2 .

    Techniques: Knock-Out, Expressing, Western Blot, Derivative Assay, Transformation Assay, Staining, Control

    Nrf2 modulates the 1,4‐D‐induced EMT process via SDC4 and SDC4‐enriched EVs. (A) ChIP‐seq analysis identifies Nrf2 binding peaks across the SDC4 gene body, with notable enrichment at the transcription start site (TSS), exon 1, and the first intron. Many of these peaks contain conserved antioxidant response element (ARE) featuring the core sequence TGAG/CTC. The predicted ARE sites on the SDC4 gene are marked with green numbers. (B) ChIP‐qPCR analysis showing Nrf2 occupancy at these ARE elements on the SDC4 gene. Data are presented as mean ± SD, n = 3, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (C) Representative immunoblots showing the abundance of SDC4 in 1,4‐D‐transformed WT cells with SDC4 knockdown by siRNA and in 1,4‐D‐transformed Nrf2 KO cells with SDC4 overexpression via the pcDNA3.1 vector. (D) Representative images from wound healing assay illustrating the effects of SDC4 regulation on the migration capabilities of 1,4‐D‐transformed WT and Nrf2 KO cells. (E) Representative immunoblots showing the abundance of SDC4, COL12A1, CAPG, NNMT and ACTB in EV samples derived from 1,4‐D‐transformed WT cells with SDC4 knockdown and from 1,4‐D‐transformed Nrf2 KO cells with SDC4 overexpression. (F) The effects of EVs derived from the indicated groups on A549 cell proliferation were determined by MTT assay. Data are presented as mean ± SD, n = 6, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test or unpaired Student's t test). (G and H) Representative images illustrating changes in migration and invasion capabilities of A549 cells treated with EVs from the indicated groups, with quantification of migrated or invasive cells. Data are presented as mean ± SD, n = 10, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test or unpaired Student's t test).

    Journal: Journal of Extracellular Vesicles

    Article Title: 1,4‐Dioxane Induces Epithelial‐Mesenchymal Transition and Carcinogenesis in an Nrf2‐Dependent Manner

    doi: 10.1002/jev2.70072

    Figure Lengend Snippet: Nrf2 modulates the 1,4‐D‐induced EMT process via SDC4 and SDC4‐enriched EVs. (A) ChIP‐seq analysis identifies Nrf2 binding peaks across the SDC4 gene body, with notable enrichment at the transcription start site (TSS), exon 1, and the first intron. Many of these peaks contain conserved antioxidant response element (ARE) featuring the core sequence TGAG/CTC. The predicted ARE sites on the SDC4 gene are marked with green numbers. (B) ChIP‐qPCR analysis showing Nrf2 occupancy at these ARE elements on the SDC4 gene. Data are presented as mean ± SD, n = 3, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test). (C) Representative immunoblots showing the abundance of SDC4 in 1,4‐D‐transformed WT cells with SDC4 knockdown by siRNA and in 1,4‐D‐transformed Nrf2 KO cells with SDC4 overexpression via the pcDNA3.1 vector. (D) Representative images from wound healing assay illustrating the effects of SDC4 regulation on the migration capabilities of 1,4‐D‐transformed WT and Nrf2 KO cells. (E) Representative immunoblots showing the abundance of SDC4, COL12A1, CAPG, NNMT and ACTB in EV samples derived from 1,4‐D‐transformed WT cells with SDC4 knockdown and from 1,4‐D‐transformed Nrf2 KO cells with SDC4 overexpression. (F) The effects of EVs derived from the indicated groups on A549 cell proliferation were determined by MTT assay. Data are presented as mean ± SD, n = 6, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test or unpaired Student's t test). (G and H) Representative images illustrating changes in migration and invasion capabilities of A549 cells treated with EVs from the indicated groups, with quantification of migrated or invasive cells. Data are presented as mean ± SD, n = 10, ** p < 0.01 vs. control (one‐way ANOVA with Bonferroni's multiple comparisons test or unpaired Student's t test).

    Article Snippet: The human bronchial epithelial cell line BEAS‐2B and the human non‐small cell lung cancer derived hypotriploid alveolar basal epithelial cells A549, purchased from the American Type Culture Collection (ATCC, Manassas, VA), were maintained in complete medium at 37°C under 5% CO 2 .

    Techniques: ChIP-sequencing, Binding Assay, Sequencing, ChIP-qPCR, Control, Western Blot, Transformation Assay, Knockdown, Over Expression, Plasmid Preparation, Wound Healing Assay, Migration, Derivative Assay, MTT Assay